The National Cancer Institute has awarded the University of Michigan Comprehensive Cancer Center a grant worth $28.4 million over five years. At the same time, the center’s designation as a “comprehensive cancer center” was renewed.
Outpatient urological surgery costs significantly less when performed in physician offices and ambulatory care centers. But results may reflect the lower cost of treating patients who are less seriously ill.
The University of Michigan Comprehensive Cancer Center is part of a national organization that has received $11.5 million to study sarcoma, a rare type of cancer that can occur in bones, muscle and fat.
Offering more than 125,000 pairs of shoes at half the manufacturer’s suggested retail price, QVC and the Fashion Footwear Association of New York are joining together for the 19th annual QVC Presents “FFANY Shoes on Sale®,” scheduled for Wednesday, Oct. 24.
A new $13.6 million program award from the National Cancer Institute awarded to a national team of researchers centered at the University of Michigan Comprehensive Cancer Center will examine how patients make treatment decisions, how doctors make treatment recommendations and how to improve the process for better outcomes.
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study. The finding provides new clues to this rare and deadly cancer type, and researchers hope it will lead to better treatments.
Hosted by the Cancer Center's Voices Art Gallery, the new "Art from the Heart" exhibit features more than 50 pieces of multimedia art from 26 different artists, all using the image of the heart as inspiration.
A new study preports that in the “PSA era,” survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the disparity between African American and Caucasian men has been resolved.
Members of Michigan’s congressional delegation were encouraged to sustain federal funding for cancer research so that progress can continue against a disease that kills an estimated 1,500 people in America each day.
As a key step toward providing patients with treatments based on their own DNA profiles, U-M and the International Genomics Consortium (IGC) have launched a new joint venture that will help usher in an age of personalized medicine.
The University of Michigan Comprehensive Cancer Center is harnessing its expertise in basic science research to speed the translation into clinical trials and new treatment opportunities for cancer patients.
Researchers at theUniversity of Michigan Comprehensive Cancer Center have found that a cancer gene linked to aggressive spread of the disease promotes breast cancer stem cells. The finding implies a new way to target the behavior of these lethal cells.
Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almost all of them will eventually become resistant.
The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2012-13 Best Children's Hospitals rankings.
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy than on intermittent therapy, according to a 17-year study led by a University of Michigan Comprehensive Cancer Center researcher.